Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 511-520 of 9364

Page
per page
  1. Zileuton
    A5384 Zileuton
    Summary: 5-lipoxygenase (5-LOX) inhibitor, orally active
  2. Risedronate Sodium
    A5293 Risedronate Sodium
    Summary: FPP synthase inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥10.17 mg/mL
  3. Linezolid
    A5181 Linezolid
    Summary: Antibacterial reagent
      ≥16.85 mg/mL
  4. AS-605240
    A5176 AS-605240
    Target: PI3K
    Summary: Potent and selective PI 3-Kγ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.28 mg/mL
  5. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  6. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  7. Tazarotene
    A5710 Tazarotene
    Summary: Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor
  8. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  9. GSK429286A
    A5611 GSK429286A
    Target: ROCK
    Summary: Selective ROCK1/ROCK2 inhibitor
      ≥21.6 mg/mL
  10. Clopidogrel
    A5183 Clopidogrel
    Target: P2Y Receptors
    Summary: P2Y12 receptor antagonist
      ≥20.995 mg/mL

Items 511-520 of 9364

Page
per page